Porcine epidemic diarrhea is a highly contagious viral disease caused by an alphacoronavirus that produces acute enteritis and severe diarrhea in pigs of all ages. First identified in England in 1971, the disease remained primarily an Asian and European concern until its devastating emergence in North America in 2013, where it caused unprecedented losses in the naive swine population. The porcine epidemic diarrhea virus (PEDv) targets the small intestinal epithelium, destroying the villous absorptive cells essential for nutrient uptake and causing profuse watery diarrhea, dehydration, and in young piglets, extremely high mortality rates approaching one hundred percent in some outbreaks. This pathogen has demonstrated remarkable capacity for rapid spread through swine populations, making it one of the most feared enteric diseases in modern pig production.
Porcine epidemic diarrhea affects pigs of all ages, though clinical severity varies dramatically with age at infection. Neonatal piglets in their first week of life suffer the most severe disease, with mortality rates often exceeding ninety percent in acute outbreaks affecting naive herds. Older suckling pigs show progressively better survival rates, though significant mortality still occurs. Growing and finishing pigs typically experience mild to moderate illness characterized by diarrhea and reduced feed intake but rarely die from the infection. Adult breeding animals develop transient diarrhea and may experience reduced milk production, affecting nursing piglets, but generally recover without complications. This age-dependent severity pattern reflects the critical importance of mature intestinal epithelium and functional immune responses in limiting disease impact.
The economic consequences of PED outbreaks can be catastrophic for affected swine operations, particularly breeding herds producing weaned pigs for sale or internal use. The loss of entire farrowing groups of piglets devastates production numbers and cash flow. Industry estimates from the 2013-2014 North American epidemic suggested losses of eight million pigs in the first year alone, with economic impacts measured in billions of dollars. Beyond direct mortality losses, PED causes significant production disruptions including reduced breeding herd productivity, delayed pig flow, increased medication costs, and substantial labor demands for managing sick animals and implementing biosecurity measures. The psychological toll on producers witnessing massive piglet losses should not be underestimated.
Early detection and rapid response are absolutely critical for limiting PED spread and minimizing losses when outbreaks occur. The extremely high environmental stability of the virus and its efficient fecal-oral transmission route enable rapid dissemination through and between farms when biosecurity fails. Recognizing early clinical signs, implementing immediate diagnostic investigation, and activating response protocols can mean the difference between containing a limited outbreak and experiencing facility-wide devastation. Vaccination and controlled exposure strategies can accelerate population immunity development, though preventing introduction through rigorous biosecurity remains the gold standard. Understanding PED epidemiology, clinical presentation, and management options enables producers and veterinarians to respond effectively when facing this formidable pathogen.
